New doesn’t mean better – it means unproven
Appeal to tradition says this is old, therefore it’s good.
Appeal to novelty says the exact opposite – this is new, therefore it’s better.
Both are wrong for the same reason. Age tells you nothing about quality, whether that age is long or short. A practice can be a thousand years old and still be useless. A product can be brand new and still not work. Neither time nor newness is evidence.
Appeal to novelty is the assumption that newer automatically means superior.
It’s the mirror image of the tradition fallacy from 15.13, and it’s just as logically empty. “Cutting-edge.” “Revolutionary.” “Next-generation.” “Disruptive.” These are signals to watch for. They do rhetorical work by implying that novelty itself is a virtue, which saves the speaker from having to prove that the new thing actually does anything better than the thing it replaced.
Tech culture is particularly vulnerable to this.
The newest framework, the latest methodology, the freshest approach – there’s enormous social pressure to adopt them before anybody has established whether they actually work better than what came before. Startups pitch novelty as an argument. Investors fund it. The disruption is the point, even when the disruption doesn’t improve anything. Companies have burned through billions chasing newness for its own sake.
Crypto was one of the clearest examples of the last decade.
Blockchain technology is genuinely novel. But novelty got offered constantly as an argument for its value – “this changes everything,” “traditional finance is obsolete,” “early adopters always win” – without serious engagement with whether specific applications solved real problems better than existing tools. For most use cases, they didn’t. The novelty was the pitch. The utility was supposed to show up later. Sometimes it did. Often it never arrived.
Medicine has a version of this too.
“Innovative treatment” or “breakthrough therapy” in the headline is not the same as evidence that it works. Every drug that failed in trials was novel at some point. Novelty generates excitement. Evidence determines effectiveness. Those are different steps, and skipping the second one because the first one was exciting is how people end up taking things that don’t work, or actively hurt them.
The flip side is also a fallacy.
Dismissing something specifically because it’s new is still treating age as the deciding factor. The right question is always about evidence, not about when something was invented. “I don’t trust anything that hasn’t been around for decades” is as empty as “I only use cutting-edge tools.” Both are judgments about time rather than about whether the thing actually works.
New things deserve scrutiny.
Not suspicion by default. Scrutiny. The same questions you’d ask about an established practice apply to a new one. What’s the evidence? Has this been tested? What do the results actually show? What are the failure modes? Who has independently verified any of this? If the pitch for the new thing can’t answer those, novelty was doing the selling.
This fallacy is especially dangerous right now because AI is accelerating the pace of everything.
New tools show up every week. Marketing claims outrun verification by months. The temptation to adopt something because it’s the latest thing is stronger than it’s ever been, and the time to evaluate what actually works has compressed to almost nothing. Which means appeal to novelty isn’t just a logic problem. It’s an economic pressure that pushes people into decisions they haven’t had time to actually think about.
“This is innovative” is a starting point for investigation.
Not a conclusion.